A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis

OBJECTIVE: The objective of the study was to confirm the efficacy and safety of Astodrimer 1% Gel to prevent recurrence of bacterial vaginosis. STUDY DESIGN: 864 women with a diagnosis of bacterial vaginosis and a history of recurrent bacterial vaginosis were enrolled in North America and first rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwebke, Jane R., Carter, Belvia A., Waldbaum, Arthur S., Agnew, Kathy J., Paull, Jeremy R.A., Price, Clare F., Castellarnau, Alex, McCloud, Philip, Kinghorn, George R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Gynaecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843408/
https://www.ncbi.nlm.nih.gov/pubmed/33537666
http://dx.doi.org/10.1016/j.eurox.2021.100121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843408/
https://www.ncbi.nlm.nih.gov/pubmed/33537666
http://dx.doi.org/10.1016/j.eurox.2021.100121

Ejemplares similares